Xi inspects work resumption in Zhejiang

Xi Jinping, general secretary of the Communist Party of China Central Committee, Sunday inspected the resumption of work and production in east China's Zhejiang Province.

Headlines

LINE
  • Self-driving in China gets investment boosts

    Self-driving in China gets investment boosts

    Mar 30,2020

    The autonomous driving subsidiary of Didi Chuxing is reportedly getting a $300-million investment from Japanese tech giant Soft-Bank, adding more fuel to the autonomous driving sector in China.

  • Aussie scientists develop COVID-19 diagnostic tool

    Mar 30,2020

    Scientists in Australia have developed a COVID-19 diagnostic tool, to help doctors identify the disease in CT scans of patients' lungs, with the potential to save thousands of lives.

  • American scientists refute Wuhan as the novel coronavirus' origin

    American scientists refute Wuhan as the novel coronavirus' origin

    Mar 30,2020

    In a recent interview with ABC news, Dr. Robert Garry, a professor at the Tulane University School of Medicine, once again pointed out that it's a misconception to believe the virus originated at a seafood market in Wuhan, China.

  • AI gives potential suicides pause for thought

    Mar 30,2020

    As an expert in artificial intelligence, Huang, senior researcher at Vrije University of Amsterdam, the Netherlands, has established a group of volunteers, including psychological counselors and medical AI experts, to support critically ill patients who post messages online asking for help.

  • Scientists worldwide search for coronavirus origin

    Scientists worldwide search for coronavirus origin

    Mar 30,2020

    "Our analyses, and others too, point to an earlier origin than that," said Garry, who is also the author of a new study on the origins of the virus that concluded that the pandemic-causing strain developed naturally.

  • U.S. steps up developing therapies against COVID-19: Trump

    Mar 30,2020

    President Donald Trump said Sunday that the country is stepping up developing treatments for COVID-19 patients, including experiment on antimalarial drug hydroxychloroquine and a blood-related therapy.

MoreEcns wire

MoreFeature

Most popular in 24h

MoreInfographics

MorePhoto
LINE
Back to top Links | About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2020 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.